The Effect of Glucocorticoid and Mineralocorticoid Receptor Antagonists in the Skin of Aged Female Mice
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26178346 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Ameena Ali und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physiology, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA. Hauptthemen laut MEDLINE: Mineralocorticoid Receptor Antagonists, Receptors, Glucocorticoid, Skin, Aging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, BLRD VA, NIA NIH HHS.
Abstract (Originalsprache)
The glucocorticoid receptor (GR) and mineralocorticoid receptor (MR) are ligand-activated transcription factors that regulate epidermal homeostasis, inflammation, and function. Prior studies using epidermal-specific conditional single and double knockout mice have shown their importance in skin physiology; however, clinically human disease is largely treated pharmacologically. Our objective was to examine how systemic MR/GR antagonism affects cutaneous gene expression and epidermal thickness in aged (18-month-old) C57BL/6J female mice. Mice were treated with selective GR (relacorilant), selective MR (eplerenone), or dual GR/MR (miricorilant) antagonists for 8 weeks. Quantitative RT-qPCR analysis of the skin showed that miricorilant significantly upregulated Sgk1, a GR/MR target. Miricorilant also increased the expression of keratinocyte differentiation markers and downregulated key inflammatory cytokines and Col3a1, a collagen subtype associated with tissue remodeling. Relacorilant suppressed Scnn1g, a subunit of the epithelial sodium channel. None of the antagonists significantly altered proliferation markers, epidermal thickness, or regulators of glucocorticoid activity. Our findings show that miricorilant downregulated inflammatory cytokines and increased differentiation marker expression without affecting epidermal thickness, suggesting its potential to treat inflammatory skin diseases. The results contrast with data from GR/MR knockout studies, highlighting the likely significance of receptor dynamics. Further studies of antagonist effects on receptor interactions with co-regulators appear warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Physiology, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
- Department of Cellular Biology and Anatomy, Medical College of Georgia at Augusta University, Augusta, GA 30912, USA.
- VA Augusta Health Care System, Augusta, GA 30904, USA.
ORCID-Profile: Husam Bensreti, Vivek Choudhary, Meghan E McGee-Lawrence, Wendy B Bollag
Förderung
- NIH HHS
- BLRD VA
- NIA NIH HHS
- National Institutes of Health Awards
- the Department of Veterans Affairs
Zitieren
APA
Ali, A., Fossas De Mello, N., Luo, Y., Bensreti, H., Melynk, S., Shaver, J. C., Choudhary, V., McGee-Lawrence, M. E., & Bollag, W. B. (2025). The Effect of Glucocorticoid and Mineralocorticoid Receptor Antagonists in the Skin of Aged Female Mice. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178346
Vancouver
Ali A, Fossas De Mello N, Luo Y, Bensreti H, Melynk S, Shaver JC, et al. The Effect of Glucocorticoid and Mineralocorticoid Receptor Antagonists in the Skin of Aged Female Mice. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178346
BibTeX
@article{Ali2025,
author = {Ali, Ameena and Fossas De Mello, Natalia and Luo, Yonghong and Bensreti, Husam and Melynk, Samuel and Shaver, Joseph C and Choudhary, Vivek and McGee-Lawrence, Meghan E and Bollag, Wendy B},
title = {The Effect of Glucocorticoid and Mineralocorticoid Receptor Antagonists in the Skin of Aged Female Mice},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26178346}
}
EUVIMED